Gastric emptying time and gastric motility in patients with Parkinson's disease

Hardoff, Ruth, Sula, Michael, Tamir, Ada, Soil, Adrian, Front, Avi, Badarna, Samich, Honigman, Silvia, Giladi, Nir·2001·Movement Disorders

Cited by (248)

Items 201–248 of 248

  1. Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying?
    Maria Nord, Anita Kullman, Ulf Hannestad, Nil Dizdar · 2017 · Advances in Parkinson s Disease
  2. Abnormal upper gastrointestinal structures underlying levodopa malabsorption
    Noriyuki Miyaue, Hayato Yabe, Masahiro Nagai, Masahiro Nomoto · 2020 · Journal of the Neurological Sciences
  3. Gastrointestinal Dysfunction in Parkinson’s Disease
    Klaus Krogh · 2011 · InTech eBooks
  4. Evidence-Based Clinical Update No evidence for decreased incidence of aspiration after rapid sequence induction (Aucune donnée probante concernant l'incidence réduite d'inhalation après l'induction en séquence rapide)
    David Neilipovitz, Edward T. Crosby · 2007
  5. Gastrointestinal Dysfunctions in Parkinson’s Disease
    Joong‐Seok Kim, Hey Young Sung · 2015 · Journal of the Korean Neurological Association
  6. Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies
    Asad Ali, Ning B. Yin, Arkam Rehman, Verline Justilien · 2016 · Medical Sciences
  7. Evaluating the Scope of Gastrointestinal Symptoms of Parkinson's Disease: A Review of the Evidence
    Hani Essa, Shaheen Hamdy · 2016 · Neuroenterology
  8. Aspiration Prevention and Prophylaxis
    Mark D. Tasch, Olivier Langeron · 2012 · Elsevier eBooks
  9. THE ROLE OF DOPAMINE-RELATED GENES IN AUTISM SPECTRUM DISORDERS: EVIDENCE FOR SPECIFIC GENES AND RISK FOR ASD IN FAMILIES WITH AFFECTED MALES
    Joseph Alan Hettinger · 2009 · QSpace (Queen's University Library)
  10. The treatment of older patients with Parkinson’s disease
    Marija Djukic, Elisabeth Yoshida-Stiksrud, Roland Nau · 2025 · Deutsches Ärzteblatt international
  11. Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment
    Quentin Damiens, Victor Mille, J. Faure, E. Toussirot, M. Valnet-Rabier, Matthieu Béreau · 2026 · Journal of Parkinson's Disease
  12. Gastrointestinal complications of movement disorders
    Jessica B. Lehosit, Leslie Jameleh Cloud · 2014 · Cambridge University Press eBooks
  13. Electrogastrographyc activity in Parkinson's disease patients with and without motor fluctuations
    Giovanni Albani, Nadia El Assawy, Stefania Cattaldo, Marilena De Gennaro, Francesca Gregorini, Luca Pradotto, Alessandro Mauro · 2011 · Movement Disorders
  14. Endometriosis of the liver
    Meera Adishesh, Amy Hawarden, D Rowlands · 2016 · British Journal of Hospital Medicine
  15. Clinical presentations of gastroparesis
    Baha Moshiree, Yellowlees Douglas · 2020 · Elsevier eBooks
  16. The fixel GI Parkinson's research and integrated support model (PRISM)
    Grace E. Hey, Manuel A. Amaris, Matthew Beke, Nur Walker-Pizarro, Candice Rogers, Vinata Vedam‐Mai, Rachael Dorsey, Nicole E. Herndon, Michael S. Okun, Adolfo Ramirez‐Zamora · 2025 · Journal of Parkinson s Disease
  17. Use of enteral access for continuous delivery of levodopa-carbidopa in patients with advanced Parkinson's disease
    Julian Chéron, Jacques M.E. Deviere, Asuncion Ballarin, Frédéric Supiot, Pierre Eisendrath, E Toussaint, Vincent Huberty, Carmen Musala, Daniel Bléro, Arnaud Lemmers et al. · 2016 · Nutrition Clinique et Métabolisme
  18. Gut Microbiome Regulation of Appetite and Role in Neurological Disorders
    Ankita Singh, O. P. Verma, Rajavashisth Tripathi · 2022 · Nutritional neurosciences
  19. Gastrointestinal and Swallowing Disturbances in Parkinson's Disease
    Ronald F. Pfeiffer · 2011 · Parkinson s Disease
  20. Correspondence: Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia
    Ruth Helen Walker, Hans Heinrich Jung, Adrian Danek · 2007 · Neurology
  21. Device‐Enabled Drug Infusion Therapies
    Keith R. Hildebrand · 2015
  22. Correspondence: Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers
    2007 · Neurology
  23. Pharmacotherapy for Parkinson's Disease - Observations and Innovations
    Dag Nyholm · 2011 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  24. Translation of Motilin and Ghrelin Receptor Agonists into Drugs for Gastrointestinal Disorders
    Gareth John Sanger, John Broad, David Alpers · 2011
  25. Should clinical trial research of psychotropic medication in autism control for gastrointestinal symptoms?
    Andrew M. Heitzer, Meredith A. Job, Nivedita K. Pandit, Maria G. Valdovinos · 2014 · The Journal of Clinical Pharmacology
  26. Treatments for progressing Parkinson's disease: a clinical case scenario study.
    Alain Maertens de Noordhout, Patrick Santens, Jean‐Marie Gérard, Michel Gonce, Anne P. Jeanjean, Anja Flamez, Barbara Anne Pickut, Michel Van Zandijcke, Rajesh Pahwa · 2009 · PubMed
  27. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1236 Pharmacotherapy for Parkinson's Disease - Observations and Innovations
    Dag Nyholm · 2003
  28. DEVELOPMENT OF AN ORAL DELIVERY SYSTEM TO MODULATE THE RELEASE OF ANTHOCYANINS EXTRACTED FROM HASKAP BERRIES (LONICERA CAERULEA L.)
    Giovana Bonat Celli · 2016
  29. Gastroparesis in a patient with Parkinson's disease
    Maheep Singh Sangha, Alok Arora, Keith L. Shulman · 2016 · British Journal of Hospital Medicine
  30. Postsurgical, Parkinson, Other Neurologic Diseases, Connective Tissue Disorders
    Eamonn M.M. Quigley · 2015
  31. Non-motor Symptom Management in Parkinson’s Disease
    EDUARDO S. TOLOSA, Carles Gaig, Lillian Acevedo · 2013
  32. Review of the available evidence on Oral Dopamine Agonists For Parkinson's Disease
    Viale Aldo Moro · 2014
  33. RBD, Gastric Peptides, and Gastric Motility
    Marcus Michael Unger, Wolfgang Hermann Oertel · 2018 · Springer eBooks
  34. Parkinsonism
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett, Peter G. Jenner · 2007 · Elsevier eBooks
  35. Assessing autonomic dysfunction with functional imaging in Parkinson's disease
    Jacob Horsager, Casper Skjærbæk, Per Borghammer · 2021 · International review of movement disorders
  36. Unpredictable motor fluctuations caused by cholecystitis in Parkinson’s disease
    Min Seung Kim, Don Gueu Park, Jung Han Yoon · 2022 · Acta Neurologica Belgica
  37. Parkinsonism
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  38. Gastrointestinal Symptoms
    Angelo Antonini · 2011
  39. Gastroparesis and Gastroparesis Syndromes as Neuromuscular Disorders
    Le Yu Naing, Prateek Mathur, Garvit Chhabra, Abigail M. Stocker, Thomas L. Abell · 2023 · Seminars in Neurology
  40. The Gut Microbiome, Microbial-Produced Pro-inflammatory Neurotoxins, and Neurological Disorders
    Monisha Prasad, Ponnulakshmi Rajagopal, Selvaraj Jayaraman · 2024 · Springer eBooks
  41. Parkinson disease and Parkinsonism
    Michael Thomas Hayes · 2024 · Elsevier eBooks
  42. Role of microbiota gut–brain axis in Parkinson's disease
    Rani Mansuri, Meenakshi Dhanawat, Shital Patel, Garima Garima, Anupama Diwan · 2025 · Elsevier eBooks
  43. Pharmakokinetik und -dynamik der Anti-Parkinson-Medikamente beim geriatrischen Patienten
    Marija Djukic, Sandra Schütze, Elisabeth Yoshida-Stiksrud, Orkhan Ismayilov, Roland Nau · 2026 · Zeitschrift für Gerontologie und Geriatrie
  44. Study of the interactions between the nervous system and the gut in Parkinson’s disease using Drosophila
    Xiaojing Yue · 2022 · theses.fr (ABES)
  45. Patient-friendly alternative to Parkinson’s treatment: oromucosal fılm formulatıons of selegılıne hydrochlorıde
    Meliha Güneş, Fadime Aydın Köse, Seda Rençber, Özgen Özer, Sinem Yaprak Karavana · 2026 · Journal of Dispersion Science and Technology
  46. Gastrointestinal manifestations of Parkinson's disease
    Ronald F. Pfeiffer, Eamonn M.M. Quigley · 2026 · Autonomic Neuroscience
  47. Effects of Adding Blenderized Tube Feeds to Commercial Enteral Formulas on Gastrointestinal Symptoms in Adult Patients Receiving Enteral Nutrition
    Athanasios Migdanis, Constantinos Giaginis, Ioanna Partsalaki, Vasiliki Bismpardi, Ioannis Migdanis, Sousana Κ. Papadopoulou, Maria Anna Polyzou Konsta, Agathi Pritsa, Odysseas Androutsos · 2026 · Medicina
  48. An acoustic-only multivariable diagnostic model for Parkinson's disease using bowel sound acoustic signatures
    Sicheng Chen, Man Zhang, Surui Fang, Qi Yang, Chuyi Chen, Zhixuan Lei, Yuxia Zhu, Fen Deng, Lijuan Mo, Xi Liu et al. · 2026 · Journal of Parkinson s Disease